nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—Crohn's disease	0.695	1	CbGaD
Pseudoephedrine—IL2—epithelium—Crohn's disease	0.00438	0.143	CbGeAlD
Pseudoephedrine—IL2—skin of body—Crohn's disease	0.00417	0.136	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—Crohn's disease	0.00369	0.12	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—Crohn's disease	0.00338	0.11	CbGeAlD
Pseudoephedrine—IL2—digestive system—Crohn's disease	0.00334	0.109	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—Crohn's disease	0.00208	0.0678	CbGeAlD
Pseudoephedrine—TNF—lymph node—Crohn's disease	0.00199	0.0647	CbGeAlD
Pseudoephedrine—IL2—lymph node—Crohn's disease	0.00191	0.062	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—Crohn's disease	0.000869	0.0283	CbGeAlD
Pseudoephedrine—SLC6A4—digestive system—Crohn's disease	0.000808	0.0263	CbGeAlD
Pseudoephedrine—MAOA—mammalian vulva—Crohn's disease	0.000747	0.0243	CbGeAlD
Pseudoephedrine—ADRA1A—lymphoid tissue—Crohn's disease	0.000669	0.0218	CbGeAlD
Pseudoephedrine—MAOA—digestive system—Crohn's disease	0.000655	0.0213	CbGeAlD
Pseudoephedrine—ADRA2A—mammalian vulva—Crohn's disease	0.000573	0.0187	CbGeAlD
Pseudoephedrine—Amphetamine—SLC22A5—Crohn's disease	0.000542	0.519	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC22A5—Crohn's disease	0.000503	0.481	CrCbGaD
Pseudoephedrine—SLC6A2—lymph node—Crohn's disease	0.000406	0.0132	CbGeAlD
Pseudoephedrine—CYP2D6—digestive system—Crohn's disease	0.000389	0.0127	CbGeAlD
Pseudoephedrine—MAOA—lymph node—Crohn's disease	0.000374	0.0122	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—Crohn's disease	0.000287	0.00935	CbGeAlD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GPR65—Crohn's disease	4.79e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR9—Crohn's disease	4.78e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—JAK2—Crohn's disease	4.74e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SOCS1—Crohn's disease	4.73e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	4.67e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—JAK2—Crohn's disease	4.65e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL6—Crohn's disease	4.59e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—SMAD3—Crohn's disease	4.57e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFNG—Crohn's disease	4.57e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TYK2—Crohn's disease	4.51e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.51e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	4.5e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TYK2—Crohn's disease	4.5e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2RA—Crohn's disease	4.47e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GPR65—Crohn's disease	4.45e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—Crohn's disease	4.41e-05	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	4.41e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	4.35e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR9—Crohn's disease	4.34e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL8—Crohn's disease	4.33e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.31e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—JAK2—Crohn's disease	4.31e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—JAK2—Crohn's disease	4.3e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	4.25e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—Crohn's disease	4.25e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	4.21e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	4.2e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—TYK2—Crohn's disease	4.12e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	4.12e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—Crohn's disease	4.09e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SMAD3—Crohn's disease	4.09e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1B—Crohn's disease	4.07e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—Crohn's disease	4.07e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLA2G4F—Crohn's disease	4.05e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—Crohn's disease	4.04e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GPR65—Crohn's disease	4.04e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	4.02e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—FADS1—Crohn's disease	4.01e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MLN—Crohn's disease	3.98e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.96e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	3.94e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—JAK2—Crohn's disease	3.93e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—Crohn's disease	3.93e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ACKR2—Crohn's disease	3.9e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNG—Crohn's disease	3.86e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ITGA4—Crohn's disease	3.86e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	3.85e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	3.83e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL2RA—Crohn's disease	3.78e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.78e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL3—Crohn's disease	3.76e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GPX4—Crohn's disease	3.76e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	3.74e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	3.73e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—Crohn's disease	3.73e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	3.71e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MLN—Crohn's disease	3.7e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	3.69e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.67e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	3.65e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	3.64e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	3.64e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GCKR—Crohn's disease	3.63e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	3.63e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.48e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	3.47e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1B—Crohn's disease	3.44e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTMR3—Crohn's disease	3.44e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.43e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—STAT3—Crohn's disease	3.41e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR9—Crohn's disease	3.41e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	3.41e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	3.39e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	3.37e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR9—Crohn's disease	3.34e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	3.3e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	3.18e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GPR65—Crohn's disease	3.17e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	3.17e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	3.16e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.16e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TYK2—Crohn's disease	3.15e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—STAT3—Crohn's disease	3.15e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GPR65—Crohn's disease	3.1e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	3.1e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	3.09e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.09e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.06e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	3.02e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—JAK2—Crohn's disease	3.01e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	3e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	2.99e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	2.98e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TYK2—Crohn's disease	2.98e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	2.96e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—STAT3—Crohn's disease	2.89e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	2.88e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL3—Crohn's disease	2.87e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—JAK2—Crohn's disease	2.85e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL3—Crohn's disease	2.81e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	2.81e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	2.79e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	2.78e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	2.76e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—Crohn's disease	2.75e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	2.73e-05	9.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	2.72e-05	9.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—FADS1—Crohn's disease	2.68e-05	9.83e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TYK2—Crohn's disease	2.67e-05	9.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.64e-05	9.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2RA—Crohn's disease	2.63e-05	9.65e-05	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.59e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	2.57e-05	9.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	2.57e-05	9.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	2.56e-05	9.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.55e-05	9.36e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—JAK2—Crohn's disease	2.54e-05	9.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	2.53e-05	9.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX4—Crohn's disease	2.51e-05	9.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	2.47e-05	9.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GCKR—Crohn's disease	2.43e-05	8.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	2.4e-05	8.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	2.39e-05	8.74e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—Crohn's disease	2.39e-05	8.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	2.38e-05	8.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.37e-05	8.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	2.35e-05	8.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	2.32e-05	8.51e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—Crohn's disease	2.32e-05	8.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	2.3e-05	8.42e-05	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.29e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR6—Crohn's disease	2.26e-05	8.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	2.25e-05	8.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.24e-05	8.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	2.21e-05	8.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR6—Crohn's disease	2.21e-05	8.11e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—Crohn's disease	2.21e-05	8.09e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—STAT3—Crohn's disease	2.21e-05	8.09e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—Crohn's disease	2.2e-05	8.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	2.17e-05	7.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	2.16e-05	7.91e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—STAT3—Crohn's disease	2.09e-05	7.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	2.09e-05	7.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RBX1—Crohn's disease	2.04e-05	7.49e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—Crohn's disease	2.02e-05	7.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	2.01e-05	7.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RBX1—Crohn's disease	2e-05	7.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	1.99e-05	7.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	1.97e-05	7.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	1.95e-05	7.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	1.94e-05	7.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.94e-05	7.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ALB—Crohn's disease	1.9e-05	6.98e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—STAT3—Crohn's disease	1.87e-05	6.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	1.83e-05	6.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	1.81e-05	6.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	1.79e-05	6.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	1.79e-05	6.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—JAK2—Crohn's disease	1.77e-05	6.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	1.75e-05	6.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FADS1—Crohn's disease	1.75e-05	6.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	1.74e-05	6.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	1.7e-05	6.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	1.7e-05	6.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL3—Crohn's disease	1.7e-05	6.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	1.66e-05	6.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL3—Crohn's disease	1.66e-05	6.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	1.65e-05	6.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	1.64e-05	6.01e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX4—Crohn's disease	1.64e-05	6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	1.63e-05	5.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	1.61e-05	5.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	1.6e-05	5.88e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCKR—Crohn's disease	1.58e-05	5.79e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—Crohn's disease	1.54e-05	5.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	1.54e-05	5.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	1.51e-05	5.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	1.5e-05	5.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	1.49e-05	5.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	1.49e-05	5.44e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—Crohn's disease	1.46e-05	5.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	1.46e-05	5.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	1.45e-05	5.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	1.45e-05	5.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	1.42e-05	5.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	1.41e-05	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	1.39e-05	5.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	1.37e-05	5.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	1.36e-05	4.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	1.35e-05	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	1.35e-05	4.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	1.33e-05	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.33e-05	4.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	1.32e-05	4.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	1.31e-05	4.79e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—Crohn's disease	1.3e-05	4.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	1.28e-05	4.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	1.27e-05	4.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	1.25e-05	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	1.23e-05	4.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.23e-05	4.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	1.21e-05	4.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.2e-05	4.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.2e-05	4.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	1.19e-05	4.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	1.16e-05	4.26e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—Crohn's disease	1.16e-05	4.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.15e-05	4.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.12e-05	4.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	1.12e-05	4.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.1e-05	4.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.09e-05	4.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	1.06e-05	3.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.04e-05	3.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.02e-05	3.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	1.02e-05	3.72e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—Crohn's disease	1.01e-05	3.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	9.98e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	9.64e-06	3.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	9.61e-06	3.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	9.27e-06	3.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	8.93e-06	3.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TYK2—Crohn's disease	8.37e-06	3.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TYK2—Crohn's disease	8.19e-06	3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JAK2—Crohn's disease	7.98e-06	2.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JAK2—Crohn's disease	7.81e-06	2.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—Crohn's disease	7.72e-06	2.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	7.29e-06	2.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	7.13e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—Crohn's disease	6.93e-06	2.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—Crohn's disease	6.78e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	6.77e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—Crohn's disease	6.75e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	6.46e-06	2.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	6.29e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	6e-06	2.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	5.89e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—Crohn's disease	5.86e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—Crohn's disease	5.73e-06	2.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	5.61e-06	2.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	5.48e-06	2.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	5.21e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—Crohn's disease	5.03e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	4.74e-06	1.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	4.4e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—Crohn's disease	4.4e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—Crohn's disease	4.09e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—Crohn's disease	4e-06	1.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	3.31e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	3.08e-06	1.13e-05	CbGpPWpGaD
